Agilvax
Business Services · New Mexico, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
5901 Indian School Rd NE, Albuquerque, N...Phone Number
(505) 200-9521Website
www.agilvax.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Agilvax
AgilVax is a leading player in cancer research, focusing on the development of targeted antibodies aimed at metastatic cancer. By combining advanced biotechnology with a deep understanding of tumor biology, the company aims to provide innovative treatment options that can enhance patients' quality of life and survival chances. AgilVax emphasizes collaboration with academic institutions to accelerate the transfer of research findings into clinical practice, striving to establish a new standard in cancer therapies. Their systematic approach to developing these antibodies ensures they are well-prepared for clinical trials and potential use in healthcare.Explore more
Agilvax Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Agilvax your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Agilvax has new funding data
Check out if Agilvax is spiking on competitors!
Earning: See what the market has to say on Agilvax recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Agilvax
Click to see if Agilvax had a recent Job posting/layoffs
Check if Agilvax has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Agilvax launches new products
Agilvax, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Agilvax
Compare insights from companies similar to Agilvax, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
1-10
Public
-
1982
MC
Michael CatelaniPresident & Chief Operating Officer & Chief Financial Officer
Company Profile Activity
Activity Insights
Agilvax is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Agilvax is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Agilvax.
Agilvax financials insights
Gather financial insights about Agilvax, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Series A
$10M
Grant
$1.2M
2021
Debt
$136K
Agilvax Tech Stack
A closer look at the technologies used by Agilvax
Most Recent Scoops
Funding
Agilvax has received an SBA PPP loan in the amount of $136,443 from WestStar Bank resulting in the retention of 4 jobs.
Funding
Funding
, biopharmaceutical company, has secured $1.5 million in funding from previous investors through an expansion of its Series A funding round, bringing the total amount raised to $10 million.
Funding
Funding
Agilvax News & Media
AgilVax Announces Expansion of Series A-1 Financing
ALBUQUERQUE, N.M.--(BUSINESS WIRE)--AgilVax Announces Expansion of Series A-1 FinancingAgilVax Announces Expansion of Series A-1 Financing
AgilVax Announces Expansion of Series A-1 FinancingAgilVax Announces Expansion of Series A-1 Financing
Venture capital news. Updated daily. VC deal news, fund news, transition news, industry news.AgilVax to Present Positive Preclinical Data for Monoclonal Antibody Targeting xCT at the American Association for Cancer Research’s Tumor Immunology and Immunotherapy Conference
ALBUQUERQUE, N.M.--(BUSINESS WIRE)--AgilVax to Present at the American Association for Cancer Research’s Tumor Immunology and Immunotherapy Conference
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Agilvax
Sign Up For FreeTo access detailed company insights
AgilVax is a leading player in cancer research, focusing on the development of targeted antibodies aimed at metastatic cancer. By combining advanced biotechnology with a deep understanding of tumor biology, the company aims to provide innovative treatment options that can enhance patients' quality of life and survival chances. AgilVax emphasizes co... Read More
